Skip to content

Clinical trials

Completed Phase 2 Hallucinations trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hallucinations Phase: Phase 2 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20091
20102
20111
20131
20141
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ACADIA Pharmaceuticals Inc.2
Novartis Pharmaceuticals2
AstraZeneca1
Axovant Sciences Ltd.1
Greater Manchester Mental Health NHS Foundation Trust1
New York State Psychiatric Institute1
University Hospital Tuebingen1
University Hospital, Caen1
Yale University1
cerbomed GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hallucinations12
Schizophrenia8
Psychotic Disorders6
Mental Disorders3
Paranoid Disorders2
Alzheimer Disease1
Cognition Disorders1
Dementia1
Dissociative Disorders1
Illusions1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.